ClinConnect ClinConnect Logo
Search / Trial NCT06382883

Lifestyle and Physical Activity as Part Of Obstructive Sleep Apnea Treatment

Launched by FILHA RY · Apr 18, 2024

Trial Information

Current as of August 19, 2025

Recruiting

Keywords

Obstructive Sleep Apnea Physical Activity Sedentary Behavior Behavioral Change

ClinConnect Summary

This clinical trial is exploring how a personalized lifestyle program, combined with CPAP therapy (a common treatment for sleep apnea), can help improve symptoms and quality of life for people with moderate to severe obstructive sleep apnea (OSA) who are overweight. The study aims to find out if tailored lifestyle changes, like increasing physical activity and reducing sedentary time, can lead to better sleep quality, improved health, and a more active lifestyle. Participants will be divided into different groups to see which approach works best.

To participate in this trial, individuals must be between 18 and 70 years old, have been diagnosed with moderate to severe OSA, and have a body mass index (BMI) over 25. Importantly, those who have previously used CPAP or have certain serious health conditions will not be eligible. Participants can expect to engage in a structured program designed to help them increase their activity levels while receiving support for their sleep apnea treatment. This study is currently recruiting participants, and it offers a chance to contribute to understanding how lifestyle changes can significantly benefit those living with sleep apnea.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • A physician-diagnosed, moderate to severe obstructive sleep apnea
  • BMI \> 25
  • Age 18- to 70-years
  • No previous CPAP-treatment
  • Exclusion Criteria:
  • Chronic Obstructive Pulmonary Disease (COPD) or other severe conditions affecting nighttime oxygenation (mild asthma is acceptable), Obesity Hypoventilation Syndrome without sleep apnea.
  • Aggressive cancer or any other condition requiring intense treatments.
  • Weight-loss medication initiated less than 3 months before recruiting
  • Conditions severely impairing daily functioning (e.g., serious mental health issues, narcolepsy, severe comorbidities, profound fibromyalgia, musculoskeletal problems significantly limiting mobility and accordingly, participation in the intervention)
  • Conditions and diseases influencing the participant's ability to make independent decisions
  • Participants under 18 years of age
  • Pregnancy

About Filha Ry

Filha Ry is a forward-thinking clinical trial sponsor dedicated to advancing medical research and innovation. With a commitment to improving patient outcomes, Filha Ry specializes in the design, management, and execution of clinical trials across various therapeutic areas. Our team of experienced professionals collaborates closely with healthcare providers, regulatory bodies, and research institutions to ensure the highest standards of quality and compliance. By leveraging cutting-edge methodologies and technologies, Filha Ry aims to accelerate the development of new therapies while prioritizing patient safety and ethical considerations in all phases of research.

Locations

Jyväskylä, , Finland

Patients applied

0 patients applied

Trial Officials

Tuula Vasankari

Principal Investigator

Filha ry (Finnish Lung Health Association)

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported